GlassScriptPhysician profile
Philip Fontenot
NPI 1790121424
$4,162.77
in general payments reported to CMS, 2019-2025
24 companies · $221 in 2025
The $221 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $95.92 · 2020: $571 · 2021: $1,868 · 2022: $603 · 2023: $628 · 2024: $176 · 2025: $221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,025.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,025.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $1,592.71 | 2020-2023 | Speedicath, Titan, Saffron |
| Teleflex LLC | $772.51 | 2021-2025 | Urolift |
| Neotract INC. | $330.18 | 2019-2020 | |
| Abbvie INC. | $157.42 | 2021-2023 | |
| Calyxo, INC. | $157.16 | 2025 | Cvac Aspiration System |
| Astellas Pharma US INC | $153.49 | 2019-2023 | Myrbetriq |
| Boston Scientific Corporation | $132.42 | 2022-2024 | Spaceoar Vue System - 10ml, Rezum Generator |
| Janssen Biotech, INC. | $118.58 | 2019-2023 | Erleada |
| Laborie Medical Technologies Corp. | $107.33 | 2020-2023 | |
| Medtronic, INC. | $92.45 | 2023-2025 | Interstim |
| Bioprotect Medical, INC. | $90.88 | 2024 | Bioprotect Balloon Implant System |
| Antares Pharma, INC. | $82.68 | 2022-2023 | Xyosted, Nocdurna, Tlando |
| Sumitomo Pharma America, INC. | $53.01 | 2023-2025 | Gemtesa |
| Allergan, INC. | $51.96 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $44.49 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $42.68 | 2023 | Welireg, Keytruda |
| Olympus America INC. | $40.40 | 2023 | Itind System |
| Urogen Pharma, INC. | $36.67 | 2022-2023 | Jelmyto |
| Urovant Sciences INC | $25.82 | 2022 | |
| Halozyme INC | $22.12 | 2023 | |
| Ambu INC. | $18.11 | 2021-2023 | |
| Axonics, INC. | $14.05 | 2022 | |
| Endo Pharmaceuticals INC. | $13.88 | 2023 | Xiaflex, Aveed |
| Acerus Pharmaceuticals Corporation | $11.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Fontenot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.